Member Info for robizm1001

You will have a nominee account holding as you probably don’t hold in certificates.

You we’re ramping it yesterday

Institutions tend to hold shares whereas those 8 million are now with traders he may be looking for a quick profit

Most people will not vote as their holding is literally worthless. They have enough votes to take this private.

Meal did not need to raise £20 million to pay compensation claims and was not waiting on FCA approval for a Scheme of Arrangement. A lot of people are buying without any research

I think it is 75% of votes cast so they already have enough. When this goes private the large shareholders can run riot. I think they were the same owners who IPO this in 2016 for £1.08 per share. There are plenty of assets but small investors can be wiped out when they need to raise money.

I want to know what they are up to.

Naughty they did not release it straightaway.

These are a bit more visible than most and it will be interesting to see what they say in the circular. All the sells have been bought which is interesting

Depends on the large shareholder

We have a large shareholder and a capital raise to pay compensation. The assets are worth millions but when it is private and out of sight will small shareholders be cheated out of what they own. I’m

Come on Iog don’t mess this up.

Why would directors buy, they knew this was coming. Big shareholders will sort it out and sell it back by ipo in 5 years.

Why?

Bad timing

Too many shares for just one seller.

Ageon has been reducing.

It is going lower and lower.

The type of companies who will bid are worth multiple billions. Do you really think they would worry when the price was £1.50 a share. AN is being to controlling in the types of partnerships he will accept. Not all countries operate like the US. No tie ups with the NHS or other European health authorities. Nobody interested in something that saves money and will change cancer diagnosis. Even long term investors are losing serious amounts of money. The ovarian test is the best available yet nobody wants it.

Do you actually hold any shares? This week and next week are really quiet so a few buys or sells will move the price. New Year is when people invest and 2023 should be a good year for Angle. All they have to do is announce positive news such as lab accreditation or Ovarian or Abbot partnership and the price doubles